Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300049 stock hub

SHE/300049 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300049is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.8B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300049

In the news

Latest news · SHE/300049

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E50.9

P25 17.1P50 24.2P75 37.8

Trailing P/E94.9

P25 23.5P50 41.3P75 83.2

ROE11.5

P25 -0.9P50 4.1P75 8.8

ROIC16.3

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300049 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

CNY

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	946
Employees Change	79%
Employees Change Percent	9.11
Enterprise value	CNY 14.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100000KG1
Last refreshed	2026-05-10
Market cap	CNY 14.8B
Price	CNY 55.95
Price currency	CNY
Rev Per Employee	1,717,893.73x
Sector	Healthcare
Sic	2834
Symbol	she/300049
Website	https://www.fu-rui.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.06%
EV Earnings	93.2x
EV/EBIT	36.46x
EV/EBITDA	29.02x
EV/FCF	79.05x
EV/Sales	9.02x
FCF yield	1.25%
Forward P/E	50.86x
P/B ratio	5.98x
P/E ratio	94.94x
P/S ratio	9.12x
PE Ratio10 Y	133.24x
PE Ratio3 Y	98.95x
PE Ratio5 Y	78.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.73%
EBITDA Margin	29.68%
FCF margin	11.41%
Gross margin	74.53%
Gross Profit	CNY 1.2B
Gross Profit Growth	20.55%
Gross Profit Growth Q	6.34%
Gross Profit Growth3 Y	15.78%
Gross Profit Growth5 Y	16.99%
Net Income	CNY 157.2M
Net Income Growth	58.51%
Net Income Growth Q	11.03%
Net Income Growth Quarters	3%
Net Income Growth Years	7%
Net Income Growth3 Y	15.43%
Net Income Growth5 Y	19.73%
Pretax Margin	22.37%
Profit Margin	9.68%
Profit Per Employee	CNY 166,223
Profitable Years	20
ROA	7.73
Roa5y	5.71
ROCE	13.49
ROE	11.52
Roe5y	9.48
ROIC	16.32
Roic5y	13.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.93%
Cagr15y	13.81%
Cagr1y	73.93%
Cagr3y	25.97%
Cagr5y	47.24%
Div CAGR10	2.92%
Div CAGR3	25.99%
Div CAGR5	14.87%
EPS Growth	56.1
EPS Growth Q	11.63
EPS Growth Quarters	3
EPS Growth Years	3
EPS Growth3 Y	14.9
EPS Growth5 Y	18.78
FCF Growth	747.32%
FCF Growth Q	110.49%
FCF Growth3 Y	19.51%
FCF Growth5 Y	25.25%
OCF Growth	42.45%
OCF Growth Q	21.72%
OCF Growth10 Y	8.2%
OCF Growth3 Y	18.18%
OCF Growth5 Y	16.8%
Revenue Growth	19.79x
Revenue Growth Q	9x
Revenue Growth Quarters	13x
Revenue Growth Years	5x
Revenue Growth3 Y	15.98x
Revenue Growth5 Y	15.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.5
Assets	CNY 3.4B
Cash	CNY 749.1M
Current Assets	CNY 1.5B
Current Liabilities	CNY 441.6M
Debt	CNY 80M
Debt EBITDA	CNY 0.16
Debt Equity	CNY 0.03
Debt FCF	CNY 0.43
Equity	CNY 2.5B
Interest Coverage	115.2
Liabilities	CNY 940.1M
Long Term Assets	CNY 1.9B
Long Term Liabilities	CNY 498.5M
Net Cash	CNY 669.1M
Net Cash By Market Cap	CNY 4.51
Net Cash Growth	2.39%
Net Debt EBITDA	CNY -1.39
Net Debt Equity	CNY -0.27
Net Debt FCF	CNY -3.61
Tangible Book Value	CNY 1.2B
Tangible Book Value Per Share	CNY 4.61
WACC	2.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.44
Inventory Turnover	2.84
Net Working Capital	CNY 328.1M
Quick ratio	2.7
Working Capital	CNY 1.1B
Working Capital Turnover	CNY 1.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.54%
Dividend per share	CNY 0.02
Dividend Yield	0.03%
Last Dividend	CNY 0.2
Payout Ratio	1.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	157.62%
1Y total return	73.87%
200-day SMA	63.46
3Y total return	99.91%
50-day SMA	56.42
50-day SMA vs 200-day SMA	50under200
5Y total return	591.95%
All Time High	90.68
All Time High Change	-38.3%
All Time High Date	2025-09-18
All Time Low	4.29
All Time Low Change	1,204.2%
All Time Low Date	2013-06-25
ATR	2.83
Beta	-0.33
Beta1y	0.44
Beta2y	0.96
Ch YTD	-20.54
High	57.47
High52	90.68
High52 Date	2025-09-18
High52ch	-38.3%
Low	50.9
Low52	29.58
Low52 Date	2025-05-22
Low52ch	89.15%
Ma50ch	-0.84%
Price vs 200-day SMA	-11.84%
RSI	51.28
RSI Monthly	54.36
RSI Weekly	43.9
Sharpe ratio	1.2x
Sortino ratio	2.52
Total Return	-1.51%
Tr YTD	-20.54
Tr15y	596.06%
Tr1m	0.23%
Tr1w	9.84%
Tr3m	-14.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 401.9M
Operating Income Growth	46.04
Operating Income Growth Q	3.52
Operating Income Growth3 Y	23.14
Operating Income Growth5 Y	25.17
Operating margin	24.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	204,929,358%
Net Borrowing	-3,461,969
Shares Insiders	15.83%
Shares Institutions	21.4%
Shares Out	264,975,900
Shares Qo Q	-3.11%
Shares Yo Y	1.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 185.4M
Average Volume	7,268,234.9x
Bv Per Share	7.48
CAPEX	CNY -182.5M
Ch10y	151
Ch15y	561.3
Ch1m	0.23
Ch1w	9.84
Ch1y	73.87
Ch3m	-14.4
Ch3y	98.33
Ch5y	586.5
Ch6m	-28.13
Change	8.85%
Change From Open	8.83
Close	51.4
Days Gap	0.02
Depreciation Amortization	80,425,503
Dollar Volume	844,905,258.2
Earnings Date	2026-04-28
EBIT	CNY 401.9M
EBITDA	CNY 482.4M
EPS	CNY 0.59
F Score	6
FCF	CNY 185.4M
FCF EV Yield	1.27x
FCF Per Share	CNY 0.7
Financing CF	-61,564,262
Fiscal Year End	December
Founded	1,998
Goodwill	179,499,406
Graham Number	9.95894
Graham Upside	-82.2
Income Tax	CNY 94.7M
Investing CF	-234,575,602
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2015-07-06
Last Split Type	Forward
Lynch Fair Value	CNY 11.63
Lynch Upside	-79.22
Ma150	66.77
Ma150ch	-16.2%
Ma20	55.57
Ma20ch	0.69%
Net CF	63,837,545
Open	51.41
P FCF Ratio	79.96
P OCF Ratio	40.3
Position In Range	76.86
Ppne	578,925,655
Price Date	2026-05-08
Price EBITDA	CNY 30.73
Ptbv Ratio	12.15
Relative Volume	2.26x
Revenue	1,625,127,465x
Tax By Revenue	5.82x
Tax Rate	26.04%
Tr6m	-28.13%
Volume	15,101,077

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300049 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.0%

$0.01 annual per share

Payout ratio

+1.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+14.9%

Annualized growth of the per-share dividend

Total shareholder yield

-1.5%

Dividend yield + buyback yield combined

Performance

SHE/300049 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300049?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.4%

Share of float held by funds and institutions

Insider ownership

+15.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.5%

Negative means the company is buying back shares.

Technical

SHE/300049 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.3

Neutral momentum band

Price vs 200-day MA

-11.8%

50/200-day relationship not available

Beta (5Y)

-0.33

Less volatile than the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300049

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300049 stock rating?

she/300049 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300049 analysis?

The full report lives at /stocks/she/300049/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300049?

The latest report frames she/300049 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300049 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.